Dr. Olino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
Smilow Cancer Center
New Haven, CT 06510Phone+1 203-737-8875
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2013 - 2015
- Johns Hopkins UniversityResidency, Surgery, 2005 - 2013
- Johns Hopkins University School of MedicineClass of 2005
Certifications & Licensure
- NY State Medical License 2013 - 2026
- CT State Medical License 2018 - 2025
- TX State Medical License 2015 - 2019
- MD State Medical License 2007 - 2013
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Awards, Honors, & Recognition
- Texas Rising Star Super Doctors, 2018
Clinical Trials
Publications & Presentations
PubMed
- Circulating tumor-reactive KIRCD8T cells suppress anti-tumor immunity in patients with melanoma.Benjamin Y Lu, Liliana E Lucca, Wesley Lewis, Jiping Wang, Catarina V Nogueira
Nature Immunology. 2024-11-28 - Achieving Adherence With NCCN Guidelines for Nonmelanoma Skin Cancer Regarding Peripheral and Deep En Face Margin Assessment (PDEMA).Yaohui G Xu, Young Lim, Jeremy S Bordeaux, Sumaira Z Aasi, Murad Alam
Journal of the National Comprehensive Cancer Network. 2024-11-01 - Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era.Daniel Y Lee, Madeline McNamara, Alexander Yang, Maxim Yaskolko, Harriet Kluger
Pigment Cell & Melanoma Research. 2024-11-01
Journal Articles
- Prevalence of False-Negative Results of Intraoperative Consultation on Surgical Margins During Resection of Gastric and Gastroesophageal AdenocarcinomaDaniel G Coit, Kelly Olino, David S Klimstra, Kambiz Kamrani, Murray F Brennan, JAMA
Press Mentions
- Yale Study Highlights Unmet Needs for Patients with Melanoma Who Progress or Relapse After Immunotherapy TreatmentAugust 30th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: